CTOR CITIUS ONCOLOGY, INC.

Nasdaq www.citiusonc.com/overview/default.aspx


$ 1.70 $ -0.02 (-1.14 %)    

Wednesday, 15-Oct-2025 11:54:32 EDT
QQQ $ 600.93 $ -2.89 (-0.48 %)
DIA $ 462.93 $ -1.72 (-0.37 %)
SPY $ 663.82 $ -2.96 (-0.44 %)
TLT $ 90.53 $ -0.43 (-0.47 %)
GLD $ 386.58 $ 0.59 (0.15 %)
$ 1.7
$ 1.80
$ 1.74 x 57
$ 1.77 x 300
$ 1.71 - $ 1.80
$ 0.55 - $ 6.19
101,023
na
121.64M
$ -0.97
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 02-14-2025 12-31-2024 10-Q
4 12-27-2024 09-30-2024 10-K
5 08-09-2024 06-30-2024 10-Q
6 05-20-2024 03-31-2024 10-Q
7 04-16-2024 12-31-2023 10-K
8 11-20-2023 09-30-2023 10-Q
9 08-16-2023 06-30-2023 10-Q
10 05-15-2023 03-31-2023 10-Q
11 04-17-2023 12-31-2022 10-K
12 11-28-2022 09-30-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Exclusive relationship through Named Patient Programs establishes footprint in Greece, Cyprus and additional Balkan countriesCR...

Core News & Articles

Maxim Group analyst Michael Okunewitch upgrades Citius Oncology (NASDAQ:CTOR) from Hold to Buy and announces $6 price target.

Core News & Articles

Citius Oncology, Inc. ("Citius Oncology") (NASDAQ:CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc...

Core News & Articles

Proprietary model informs targeted sales and marketing strategies with feedback loop thataugments precision and impact of targe...

Core News & Articles

Citius Oncology (NASDAQ:CTOR) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.1...

Core News & Articles

Citius Oncology, Inc. ("Citius Oncology" or the "Company") (NASDAQ:CTOR), a majority-owned subsidiary of Citius...

Core News & Articles

Agreement with global pharmaceutical solutions provider enhances commercial infrastructure and reinforces launch readiness for ...

Core News & Articles

-SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION